摩根大通-中国医疗:两日医疗路演调研收获:创新门槛抬升,业务拓展更优化,AI药物发现营收可验证-China Healthcare Two-day Healthcare Tour takeaways:Rising innovation bar,smarter BD,and verifiable AIDD revenue-20280526【8页】

发表回复

后才能评论